Related Experiment Video
Updated: May 26, 2026

Lipid Vesicle-mediated Affinity Chromatography using Magnetic Activated Cell Sorting (LIMACS): a Novel Method to Analyze Protein-lipid Interaction
Published on: April 26, 2011
Chemical biology of lipidated proteins
Gemma Triola1, Herbert Waldmann, Christian Hedberg
1Abteilung Chemische Biologie, Max-Planck-Institut für molekulare Physiologie, Dortmund, Germany. gemma.triola@mpi-dortmund.mpg.de
Abstract:
Many signaling proteins such as the members of the Ras superfamily of GTPases are posttranslationally modified by covalent attachment of lipid groups, which is crucial for the correct localization and function of these proteins. Numerous lipidated proteins are oncogens often found mutated in several human cancers. Therefore, several therapeutic strategies have been developed based on the inhibition of the enzymes involved in these lipidation steps. Here, we will summarize the results on protein lipidation inhibition, mainly focusing on the small molecules targeting the isoprenylation and acylation of proteins.
Insights
Targeting protein lipidation, crucial for signaling proteins like Ras GTPases, offers new cancer therapies. This review focuses on small molecules inhibiting protein isoprenylation and acylation.
Area of Science:
- Biochemistry
- Molecular Biology
- Oncology
Background:
- Post-translational lipidation is essential for signaling protein localization and function.
- Aberrant lipidation of proteins, particularly Ras GTPases, is implicated in human cancers.
- Targeting lipidation pathways presents a promising therapeutic strategy for cancer treatment.
Purpose of the Study:
- To review the therapeutic strategies for inhibiting protein lipidation.
- To focus on small molecules targeting protein isoprenylation and acylation.
- To summarize current findings in protein lipidation inhibition for cancer therapy.
Main Methods:
- Literature review of studies on protein lipidation inhibition.
- Focus on small molecule inhibitors.
- Analysis of targets including isoprenylation and acylation enzymes.
Main Results:
- Protein lipidation, including isoprenylation and acylation, is a key regulatory mechanism.
- Inhibition of lipidation enzymes can impede the function of oncogenic proteins.
- Small molecules targeting these enzymes show potential in preclinical studies.
Conclusions:
- Inhibiting protein lipidation is a viable strategy for developing novel cancer therapeutics.
- Targeting isoprenylation and acylation pathways offers specific avenues for drug development.
- Further research into small molecule inhibitors is warranted to advance cancer treatment.
Related Concept Videos
Lipids as Anchors
The carboxy-terminal of most of the prenylated proteins, such as Ras proteins, contains the...
Ligand Binding Sites
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Receptor-mediated Endocytosis
Mechanisms of Membrane Domain Formation
Another mechanism for membrane domain formation involves membrane proteins interacting with cytoskeletal...
Membrane Lipids
Phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, and sphingomyelin are the most common phospholipids present in mammalian membranes. At physiological pH, phosphatidylserine is negatively charged, while the other three...

